健康大视野·医学分册2023,Issue(1) :19-21.

左氧氟沙星联合头孢哌酮舒巴坦治疗老年肺炎的疗效及对患者肺功能和不良反应的影响

Efficacy of levofloxacin combined with cefoperazone-sulbactam in the treatment of senile pneumonia and its effect on pulmonary function and adverse reactions

范文鹏
健康大视野·医学分册2023,Issue(1) :19-21.

左氧氟沙星联合头孢哌酮舒巴坦治疗老年肺炎的疗效及对患者肺功能和不良反应的影响

Efficacy of levofloxacin combined with cefoperazone-sulbactam in the treatment of senile pneumonia and its effect on pulmonary function and adverse reactions

范文鹏1
扫码查看

作者信息

  • 1. 曲阜市尼山中心卫生院,山东 济宁 273100
  • 折叠

摘要

目的:探究分析老年肺炎患者联合采用左氧氟沙星与头孢哌酮舒巴坦治疗的疗效及对其肺功能、不良反应的影响.方法:选择2020年10月-2022年8月我院诊治的老年肺炎患者200例,随机分为对照组(头孢哌酮舒巴坦治疗,n=100例)和研究组(左氧氟沙星联合头孢哌酮舒巴坦治疗,n=100例),对比两组老年患者临床疗效,并测定老年患者治疗前后的肺功能指标、炎性因子指标,最后观察老年患者用药期间的不良反应.结果:研究组老年患者临床疗效率98.00%,高于对照组,P < 0.05;且治疗后研究组老年患者FVC、FEV1、

Abstract

Objective To explore and analyze the efficacy of levofloxacin combined with cefoperazone-sulbactam in the treatment of elderly patients with pneumonia and the effect on pulmonary function and adverse reactions.Methods: A total of 200 elderly pneumonia patients diagnosed and treated in our hospital from October 2020 to August 2022 were selected and randomly divided into the control group (treatment with cefoperazone-sulbactam, n=100 cases) and the study group (levofloxacin combined with cefoperazone).Sulbactam treatment, n=100 cases), the clinical efficacy of the two groups of elderly patients was compared, and the pulmonary function indexes and inflammatory factor indexes of the elderly patients before and after treatment were measured, and finally the adverse reactions of the elderly patients during the medication were observed.Results: The clinical efficacy rate of the elderly patients in the study group was 98.00%, which was higher than that in the control group, P<0.05; and the FVC, FEV1, and PEF of the elderly patients in the research group after treatment were higher than those in the elderly patients in the control group after treatment, P<0.05; The levels of CRP, TNF-α, IL-6 and PCT in the elderly patients in the group were lower than those in the elderly patients in the control group after treatment, P<0.05; finally, in terms of adverse drug reactions, there was no significant difference between the two groups of elderly patients, P>0.05.Conclusion: The combination of levofloxacin and cefoperazone-sulbactam in elderly patients with pneumonia has a reliable curative effect, can significantly improve the pulmonary ventilation function, and reduce the inflammatory reaction without significantly increasing the adverse drug reactions, which is worthy of promotion.

关键词

老年肺炎/左氧氟沙星/头孢哌酮舒巴坦/肺功能/炎性指标/不良反应

Key words

elderly pneumonia/levofloxacin/cefoperazone-sulbactam/pulmonary function/inflammatory indexes/adverse reactions

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
段落导航相关论文